Last updated on October 2018

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or S zary Syndrome (SS)


Brief description of study

The purpose of this study is to determine whether resminostat will be able to delay or prevent worsening of disease in patients with advanced stage mycosis fungoides or Szary Syndrome that have recently achieved disease control with previous systemic therapy.

Clinical Study Identifier: NCT02953301

Contact Investigators or Research Sites near you

Start Over

Chief Medical Officer

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milano, Italy
  Connect »